Literature DB >> 29417421

Myocardial perfusion imaging prior to coronary revascularization: From risk stratification to procedure guidance.

Patrick Proctor1,2, Firas Al Solaiman3,4, Fadi G Hage3,4.   

Abstract

Mesh：

Year:  2018        PMID： 29417421     DOI： 10.1007/s12350-018-1221-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  26 in total

1.  Long-term prognostic value of stress myocardial perfusion imaging and coronary computed tomography angiography: A meta-analysis.

Authors:  Valeria Cantoni; Roberta Green; Wanda Acampa; Mario Petretta; Domenico Bonaduce; Marco Salvatore; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2016-01-12       Impact factor: 5.952

2.  Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.

Authors:  Stephanie El-Hajj; Wael A AlJaroudi; Ayman Farag; Steven Bleich; Padma Manaoragada; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-05-28       Impact factor: 5.952

3.  Medical therapy for the treatment of myocardial ischemia.

Authors:  Ayman A Farag; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-03-31       Impact factor: 5.952

4.  The effect of coronary revascularization on regional myocardial blood flow as assessed by stress positron emission tomography.

Authors:  Robert M Bober; Caleb D Thompson; Daniel P Morin
Journal:  J Nucl Cardiol       Date:  2016-03-28       Impact factor: 5.952

5.  Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.

Authors:  Leslee J Shaw; William S Weintraub; David J Maron; Pamela M Hartigan; Rory Hachamovitch; James K Min; Marcin Dada; G B John Mancini; Sean W Hayes; Robert A O'Rourke; John A Spertus; William Kostuk; Gilbert Gosselin; Bernard R Chaitman; Merill Knudtson; John Friedman; Piotr Slomka; Guido Germano; Eric R Bates; Koon K Teo; William E Boden; Daniel S Berman
Journal:  Am Heart J       Date:  2012-08       Impact factor: 4.749

6.  The prognostic value of regadenoson myocardial perfusion imaging.

Authors:  Fadi G Hage; Gopal Ghimire; Davis Lester; Joshua Mckay; Steven Bleich; Stephanie El-Hajj; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2015-02-14       Impact factor: 5.952

Review 7.  Serial myocardial perfusion imaging: defining a significant change and targeting management decisions.

Authors:  Ami E Iskandrian; Fadi G Hage; Leslee J Shaw; John J Mahmarian; Daniel S Berman
Journal:  JACC Cardiovasc Imaging       Date:  2014-01

8.  Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.

Authors:  Rory Hachamovitch; Sean W Hayes; John D Friedman; Ishac Cohen; Daniel S Berman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

9.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

10.  Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction.

Authors:  Robert J Mentz; Mona Fiuzat; Linda K Shaw; Afshin Farzaneh-Far; Christopher M O'Connor; Salvador Borges-Neto
Journal:  Open Heart       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.